Thomas Marsland
Thomas Marsland publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.
- World rank
- #3,011,402 of 7,710,434 ranked researchers
- Rank in United States
- #864,048 of 1,627,098
- Works
- 30
- Citations
- 1.1k
- Citations per work
- 37.5
What does Thomas Marsland research?
Thomas Marsland's work is mostly in Medicine (70%), Economics, Econometrics and Finance (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2169.8%
- Medicine2169.8%
- Everything else619.4%
- Social Sciences310.8%
- 1Pulmonary and Respiratory Medicine30% of their works
- 2Oncology23% of their works
- 3Economics and Econometrics11% of their works
- 4Surgery7% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Hepatology4% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Economic and Financial Impacts of Cancer
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Treatment and Pharmacology
- Intraperitoneal and Appendiceal Malignancies
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe Thomas Marsland's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, CT Screening, Lung Cancer and Genomic Profiles.
- Taxanes
- Intraperitoneal Chemotherapy
- Health Utility Measures
- Cost-effectiveness Analysis
- Financial Toxicity
- Quality of Life
- Genomic Profiles
- CT Screening
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Lung Cancer
- Small-Cell Lung Cancer
- Cost of Care
- Chemotherapy-Induced Peripheral Neuropathy
- Cytoreductive Surgery
- Hepatocellular Carcinoma
- Liver Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Clinical Trials202 topics
- Targeted Therapy202 topics
- Chemotherapy192 topics
- ALK Inhibitors121 topic
- EGFR Mutations121 topic
- CT Screening111 topic
- Lung Cancer111 topic
- Genomic Profiles81 topic
- Small-Cell Lung Cancer81 topic
- Quality of Life62 topics
- Cost of Care41 topic
- Financial Toxicity41 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Cost-effectiveness Analysis31 topic
- Cytoreductive Surgery31 topic
- Health Utility Measures31 topic
- Hepatocellular Carcinoma31 topic
- Intraperitoneal Chemotherapy31 topic
- Liver Cancer31 topic
- Taxanes31 topic
Where does Thomas Marsland work?
Thomas Marsland's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Thomas Marsland have?
OpenAlex counts 30 works and 1,125 citations for Thomas Marsland, an h-index of 14, ranking #3,011,402 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas Marsland. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.